Pacira BioSciences, Inc. Email Format
Pharmaceutical ManufacturingCalifornia, United States501-1000 Employees
Pacira BioSciences, Inc. is a mid-sized pharmaceutical company based in Brisbane, California, focused on non-opioid pain management. Since its founding in 2006, it has pursued targeted, long-acting non-opioid therapies and advances in patient care to address unmet needs in pain treatment. The company also maintains offices in San Diego, Parsippany, Tampa, and Swindon, UK, and emphasizes expanding its portfolio toward innovative approaches such as gene therapy, all while aiming to improve patient outcomes and quality of life. It serves patients and clinicians by offering non-opioid treatment options that broaden the care landscape and address pain beyond traditional approaches. Within the pharmaceutical manufacturing field, Pacira's work includes ongoing research and development to broaden its portfolio. In late 2025, Pacira announced an exclusive worldwide license and collaboration with AmacaThera to develop AMT-143, a long-acting formulation of ropivacaine for postsurgical pain control.